Lymphatics in lung disease

Annals of the New York Academy of Sciences

Volumn 1131, Issue , 2008, Pages 195-202

  El Chemaly, Souheil ^a   Levine, Stewart J ^a   Moss, Joel ^a  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

Lymphangiectasis; Lymphangiogenesis; Lymphangioleiomyomatosis; Metastasis; VEGF C; VEGF D

Indexed keywords

ANTIBIOTIC AGENT; BLEOMYCIN; CORTICOSTEROID; IMMUNOGLOBULIN; PODOPLANIN; VASCULOTROPIN A; VASCULOTROPIN C; VASCULOTROPIN D;

ASTHMA; BACTERIAL INFECTION; BRONCHIOLITIS OBLITERANS; CONFERENCE PAPER; FIBROSING ALVEOLITIS; KAPOSI SARCOMA; LUNG DEVELOPMENT; LUNG DISEASE; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; LUNG TRANSPLANTATION; LYMPH FLOW; LYMPHANGIECTASIS; LYMPHANGIOGENESIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; ORGANOGENESIS; PATHOGENESIS; PLEURA EFFUSION; TUBERCULOSIS;

ANIMALIA;

EID: 44449153475     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1413.017     Document Type: Conference Paper

References (80)

1. Whitsett, J.A. 2002. Intrinsic and innate defenses in the lung: intersection of pathways regulating lung morphogenesis, host defense, and repair. J. Clin. Invest. 109 : 565 569.
2. Adams, R.H. & K. Alitalo. 2007. Molecular regulation of angiogenesis and lymphangiogenesis. Nat. Rev. Mol. Cell Biol. 8 : 464 478.
3. Armulik, A., A. Abramsson & C. Betsholtz. 2005. Endothelial/pericyte interactions. Circ. Res. 97 : 512 523.
4. Wigle, J.T. et al. 2002. An essential role for Prox1 in the induction of the lymphatic endothelial cell phenotype. EMBO J. 21 : 1505 1513.
5. Banerji, S. et al. 1999. LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan. J. Cell Biol. 144 : 789 801.
6. Kaipainen, A. et al. 1995. Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development. Proc. Natl. Acad. Sci. USA 92 : 3566 3570.
7. Roy, H., S. Bhardwaj & S. Yla-Herttuala. 2006. Biology of vascular endothelial growth factors. FEBS Lett. 580 : 2879 2887.
8. Yuan, L. et al. 2002. Abnormal lymphatic vessel development in neuropilin 2 mutant mice. Development 129 : 4797 4806.
9. Oliver, G. & K. Alitalo. 2005. The lymphatic vasculature: recent progress and paradigms. Annu. Rev. Cell Dev. Biol. 21 : 457 483.
10. Hong, Y.K. & M. Detmar. 2003. Prox1, master regulator of the lymphatic vasculature phenotype. Cell Tissue Res. 314 : 85 92.
11. Karkkainen, M.J. et al. 2004. Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins. Nat. Immunol. 5 : 74 80.
12. Baldwin, M.E. et al. 2005. Vascular endothelial growth factor D is dispensable for development of the lymphatic system. Mol. Cell Biol. 25 : 2441 2449.
13. Dumont, D.J. et al. 1998. Cardiovascular failure in mouse embryos deficient in VEGF receptor-3. Science 282 : 946 949.
14. Greenberg, J.M. et al. 2002. Mesenchymal expression of vascular endothelial growth factors D and A defines vascular patterning in developing lung. Dev. Dyn. 224 : 144 153.
15. Orlandini, M. & S. Oliviero. 2001. In fibroblasts Vegf-D expression is induced by cell-cell contact mediated by cadherin-11. J. Biol. Chem. 276 : 6576 6581.
16. Kukk, E. et al. 1996. VEGF-C receptor binding and pattern of expression with VEGFR-3 suggests a role in lymphatic vascular development. Development 122 : 3829 3837.
17. Carmeliet, P. et al. 1996. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 380 : 435 439.
18. Ferrara, N. et al. 1996. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 380 : 439 442.
19. Mallory, B.P. et al. 2006. Lymphangiogenesis in the developing lung promoted by VEGF-A. Microvasc. Res. 72 : 62 73.
20. Ramirez, M.I. et al. 2003. T1alpha, a lung type I cell differentiation gene, is required for normal lung cell proliferation and alveolus formation at birth. Dev. Biol. 256 : 61 72.
21. Schacht, V. et al. 2003. T1alpha/podoplanin deficiency disrupts normal lymphatic vasculature formation and causes lymphedema. EMBO J. 22 : 3546 3556.
22. Ayadi, A. et al. 2001. Net-targeted mutant mice develop a vascular phenotype and up-regulate egr-1. EMBO J. 20 : 5139 5152.
23. Houfflin, V. et al. 1993. [Partial 12q trisomy and chylothorax]. J. Gynecol. Obstet. Biol. Reprod. (Paris) 22 : 625 629.
24. Huang, X.Z. et al. 2000. Fatal bilateral chylothorax in mice lacking the integrin alpha9beta1. Mol. Cell Biol. 20 : 5208 5215.
25. Wang, J.F., X.F. Zhang & J.E. Groopman. 2001. Stimulation of beta 1 integrin induces tyrosine phosphorylation of vascular endothelial growth factor receptor-3 and modulates cell migration. J. Biol. Chem. 276 : 41950 41957.
26. Mishima, K. et al. 2007. Prox1 induces lymphatic endothelial differentiation via integrin alpha9 and other signaling cascades. Mol. Biol. Cell. 18 : 1421 1429.
27. Makinen, T. et al. 2005. PDZ interaction site in ephrinB2 is required for the remodeling of lymphatic vasculature. Genes Dev. 19 : 397 410.
28. Lassus, P. et al. 1999. Vascular endothelial growth factor in human preterm lung. Am. J. Respir. Crit. Care Med. 159 : 1429 1433.
29. Jobe, A.J. 1999. The new BPD: an arrest of lung development. Pediatr. Res. 46 : 641 643.
30. Janer, J. et al. 2006. Pulmonary vascular endothelial growth factor-C in development and lung injury in preterm infants. Am. J. Respir. Crit. Care Med. 174 : 326 330.
31. Padera, T.P. et al. 2002. Lymphatic metastasis in the absence of functional intratumor lymphatics. Science 296 : 1883 1886.
32. He, Y. et al. 2005. Vascular endothelial cell growth factor receptor 3-mediated activation of lymphatic endothelium is crucial for tumor cell entry and spread via lymphatic vessels. Cancer Res. 65 : 4739 4746.
33. He, Y. et al. 2002. Suppression of tumor lymphangiogenesis and lymph node metastasis by blocking vascular endothelial growth factor receptor 3 signaling. J. Natl. Cancer Inst. 94 : 819 825.
34. Tanno, S. et al. 2004. Human small cell lung cancer cells express functional VEGF receptors, VEGFR-2 and VEGFR-3. Lung Cancer 46 : 11 19.
35. Tamura, M. et al. 2004. Chest CT and serum vascular endothelial growth factor-C level to diagnose lymph node metastasis in patients with primary non-small cell lung cancer. Chest 126 : 342 346.
36. Renyi-Vamos, F. et al. 2005. Lymphangiogenesis correlates with lymph node metastasis, prognosis, and angiogenic phenotype in human non-small cell lung cancer. Clin. Cancer Res. 11 : 7344 7353.
37. Koukourakis, M.I. et al. 2005. LYVE-1 immunohistochemical assessment of lymphangiogenesis in endometrial and lung cancer. J. Clin. Pathol. 58 : 202 206.
38. Wissmann, C. & M. Detmar. 2006. Pathways targeting tumor lymphangiogenesis. Clin. Cancer Res. 12 : 6865 6868.
39. Cueni, L.N. & M. Detmar. 2006. New insights into the molecular control of the lymphatic vascular system and its role in disease. J. Invest. Dermatol. 126 : 2167 2177.
40. Kanmogne, G.D. 2005. Noninfectious pulmonary complications of HIV/AIDS. Curr. Opin. Pulm. Med. 11 : 208 212.
41. Wang, H.W. et al. 2004. Kaposi sarcoma herpesvirus-induced cellular reprogramming contributes to the lymphatic endothelial gene expression in Kaposi sarcoma. Nat. Genet. 36 : 687 693.
42. Hong, Y.K. et al. 2004. Lymphatic reprogramming of blood vascular endothelium by Kaposi sarcoma-associated herpesvirus. Nat. Genet. 36 : 683 685.
43. Elias, J.A. et al. 1999. Airway remodeling in asthma. J. Clin. Invest. 104 : 1001 1006.
44. McDonald, D.M. 2001. Angiogenesis and remodeling of airway vasculature in chronic inflammation. Am. J. Respir. Crit. Care Med. 164 : S39 45.
45. Baluk, P. et al. 2005. Pathogenesis of persistent lymphatic vessel hyperplasia in chronic airway inflammation. J. Clin. Invest. 115 : 247 257.
46. Yano, T. et al. 1994. Association of Mycoplasma pneumoniae antigen with initial onset of bronchial asthma. Am. J. Respir. Crit. Care Med. 149 : 1348 1353.
47. Xu, X. et al. 2006. Mast cells protect mice from Mycoplasma pneumonia. Am. J. Respir. Crit. Care Med. 173 : 219 225.
48. Aurora, A.B. et al. 2005. Immune complex-dependent remodeling of the airway vasculature in response to a chronic bacterial infection. J. Immunol. 175 : 6319 6326.
49. Kwan, M.L. et al. 2001. Airway vasculature after mycoplasma infection: chronic leakiness and selective hypersensitivity to substance P. Am. J. Physiol. Lung Cell Mol. Physiol. 280 : L286 297.
50. Trulock, E.P. et al. 2004. The Registry of the International Society for Heart and Lung Transplantation: twenty-first official adult lung and heart-lung transplant report - 2004. J. Heart Lung Transplant. 23 : 804 815.
51. McDyer, J.F. 2007. Human and murine obliterative bronchiolitis in transplant. Proc. Am. Thorac. Soc. 4 : 37 43.
52. Krebs, R. et al. 2005. Dual role of vascular endothelial growth factor in experimental obliterative bronchiolitis. Am. J. Respir. Crit. Care Med. 171 : 1421 1429.
53. Cursiefen, C. et al. 2004. VEGF-A stimulates lymphangiogenesis and hemangiogenesis in inflammatory neovascularization via macrophage recruitment. J. Clin. Invest. 113 : 1040 1050.
54. Kerjaschki, D. et al. 2006. Lymphatic endothelial progenitor cells contribute to de novo lymphangiogenesis in human renal transplants. Nat. Med. 12 : 230 234.
55. Adair, A. et al. 2007. Peritubular capillary rarefaction and lymphangiogenesis in chronic allograft failure. Transplantation 83 : 1542 1550.
56. Di Carlo, E. et al. 2007. Quilty effect has the features of lymphoid neogenesis and shares CXCL13-CXCR5 pathway with recurrent acute cardiac rejections. Am. J. Transplant. 7 : 201 210.
57. Belperio, J.A. et al. 2005. Role of CXCR2/CXCR2 ligands in vascular remodeling during bronchiolitis obliterans syndrome. J. Clin. Invest. 115 : 1150 1162.
58. Luckraz, H. et al. 2004. Microvascular changes in small airways predispose to obliterative bronchiolitis after lung transplantation. J. Heart Lung Transplant. 23 : 527 531.
59. Dutly, A.E. et al. 2005. A novel model for post-transplant obliterative airway disease reveals angiogenesis from the pulmonary circulation. Am. J. Transplant. 5 : 248 254.
60. Langenbach, S.Y. et al. 2005. Airway vascular changes after lung transplant: potential contribution to the pathophysiology of bronchiolitis obliterans syndrome. J. Heart Lung Transplant. 24 : 1550 1556.
61. Fisher, A.J. et al. 2005. The safety and efficacy of total lymphoid irradiation in progressive bronchiolitis obliterans syndrome after lung transplantation. Am. J. Transplant. 5 : 537 543.
62. Esther, C.R., Jr. & P.M. Barker. 2004. Pulmonary lymphangiectasia: diagnosis and clinical course. Pediatr. Pulmonol. 38 : 308 313.
63. Gardner, T.W. et al. 1983. Congenital pulmonary lymphangiectasis: a case complicated by chylothorax. Clin. Pediatr. (Phila.) 22 : 75 78.
64. Van Aerde, J et al. 1984. Spontaneous chylothorax in newborns. Am. J. Dis. Child. 138 : 961 964.
65. Barker, P.M. et al. 2004. Primary pulmonary lymphangiectasia in infancy and childhood. Eur. Respir. J. 24 : 413 419.
66. Jacquemont, S. et al. 2000. Familial congenital pulmonary lymphangectasia, non-immune hydrops fetalis, facial and lower limb lymphedema: confirmation of Njolstad's report. Am. J. Med. Genet. 93 : 264 268.
67. Light, R.W. 1995. Chylothorax and pseudochylothorax. In Pleural Diseases. D.C. Retford, Ed 284 298. Williams & Wilkins. Baltimore, MD.
68. Bower, G.C. 1964. Chylothorax: observations in 20 cases. Dis. Chest. 46 : 464 468.
69. Williams, K.R. & T.H. Burford. 1964. The management of chylothorax. Ann. Surg. 160 : 131 140.
70. Teba, L. et al. 1985. Chylothorax review. Crit. Care Med. 13 : 49 52.
71. Strausser, J.L. & M.W. Flye. 1981. Management of nontraumatic chylothorax. Ann. Thorac. Surg. 31 : 520 526.
72. Rocha, G. 2007. Pleural effusions in the neonate. Curr. Opin. Pulm. Med. 13 : 305 311.
73. Chernick, V. & M.H. Reed. 1970. Pneumothorax and chylothorax in the neonatal period. J. Pediatr. 76 : 624 632.
74. Stevenson, D.A. et al. 2006. Familial congenital non-immune hydrops, chylothorax, and pulmonary lymphangiectasia. Am. J. Med. Genet. A 140 : 368 372.
75. Chua, F., J. Gauldie & G.J. Laurent. 2005. Pulmonary fibrosis: searching for model answers. Am. J. Respir. Cell Mol. Biol. 33 : 9 13.
76. Teles-Grilo, M.L. et al. 2005. Differential expression of collagens type I and type IV in lymphangiogenesis during the angiogenic process associated with bleomycin-induced pulmonary fibrosis in rat. Lymphology 38 : 130 135.
77. Poschl, E. et al. 2004. Collagen IV is essential for basement membrane stability but dispensable for initiation of its assembly during early development. Development 131 : 1619 1628.
78. Souza, C.A. et al. 2006. Idiopathic interstitial pneumonias: prevalence of mediastinal lymph node enlargement in 206 patients. AJR Am. J. Roentgenol. 186 : 995 999.
79. Attili, A.K. et al. 2006. Thoracic lymph node enlargement in usual interstitial pneumonitis and nonspecific-interstitial pneumonitis: prevalence, correlation with disease activity and temporal evolution. J. Thorac. Imaging 21 : 288 292.
80. Basaraba, R.J. et al. 2006. Pulmonary lymphatics are primary sites of Mycobacterium tuberculosis infection in guinea pigs infected by aerosol. Infect. Immun. 74 : 5397 5401.